TALPHERA, INC. (TLPH) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-12.27M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.81× | Operating cash flow / net income. Period ending 2026-06-30. $-12.27M ÷ $-15.08M ≈ 0.81× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -12.27M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | (m) | |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -15.08M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $-12.27M | (m) | (m) | (m) | (m) | $-15.08M | (m) | (m) | (m) | 0.81× |
| 2026-03-31 | (m) | (m) | $-11.29M | (m) | (m) | (m) | (m) | $-14.25M | (m) | (m) | (m) | 0.79× |
| 2025-12-31 | (m) | (m) | $-11.36M | (m) | (m) | (m) | (m) | $-14.29M | (m) | (m) | (m) | 0.80× |
| 2025-09-30 | (m) | (m) | $-11.18M | (m) | (m) | (m) | (m) | $-12.39M | (m) | (m) | (m) | 0.90× |
| 2025-06-30 | (m) | (m) | $-11.61M | (m) | (m) | (m) | (m) | $-11.30M | (m) | (m) | (m) | 1.03× |
| 2025-03-31 | (m) | (m) | $-13.27M | (m) | (m) | (m) | (m) | $-11.64M | (m) | (m) | (m) | 1.14× |
| 2024-12-31 | $-12.68M | (m) | $-12.68M | $0.00 | (m) | (m) | (m) | $-13.00M | (m) | (m) | (m) | 0.98× |
| 2024-09-30 | $-14.38M | (m) | $-14.38M | $0.00 | (m) | (m) | (m) | $-15.65M | (m) | (m) | (m) | 0.92× |
| 2024-06-30 | $-14.40M | (m) | $-14.40M | $0.00 | (m) | (m) | (m) | $-13.65M | (m) | (m) | (m) | 1.05× |
| 2024-03-31 | $-15.13M | (m) | $-15.13M | $0.00 | (m) | (m) | (m) | $-14.20M | (m) | (m) | (m) | 1.07× |
| 2023-12-31 | $-17.59M | (m) | $-17.49M | $100.00K | (m) | (m) | (m) | $-18.40M | (m) | (m) | (m) | 0.95× |
| 2023-09-30 | $-19.10M | (m) | $-18.96M | $148.00K | (m) | (m) | (m) | $-21.36M | (m) | (m) | (m) | 0.89× |
| 2023-06-30 | $-21.54M | (m) | $-21.23M | $306.00K | (m) | (m) | (m) | $-26.76M | (m) | (m) | (m) | 0.79× |
| 2023-03-31 | $-25.02M | (m) | $-24.65M | $375.00K | (m) | (m) | (m) | $48.28M | (m) | (m) | (m) | -0.51× |
| 2022-12-31 | $-28.70M | (m) | $-28.33M | $364.00K | (m) | (m) | (m) | $47.76M | (m) | (m) | (m) | -0.59× |
| 2022-09-30 | $-31.27M | (m) | $-30.92M | $344.00K | (m) | (m) | (m) | $47.32M | (m) | (m) | (m) | -0.65× |
| 2022-06-30 | $-30.00M | (m) | $-29.63M | $370.00K | (m) | (m) | (m) | $45.70M | (m) | (m) | (m) | -0.65× |
| 2022-03-31 | $-31.12M | (m) | $-29.23M | $1.89M | (m) | (m) | (m) | $-34.82M | (m) | (m) | (m) | 0.84× |
| 2021-12-31 | $-31.83M | (m) | $-30.00M | $1.83M | (m) | (m) | (m) | $-35.10M | (m) | (m) | (m) | 0.85× |
| 2021-09-30 | $-31.75M | (m) | $-28.32M | $3.43M | (m) | (m) | (m) | $-36.10M | (m) | (m) | (m) | 0.78× |
| 2021-06-30 | $-35.81M | (m) | $-32.51M | $3.30M | (m) | (m) | (m) | $-36.66M | (m) | (m) | (m) | 0.89× |
| 2021-03-31 | $-35.66M | (m) | $-33.85M | $1.81M | (m) | (m) | (m) | $-33.41M | (m) | (m) | (m) | 1.01× |
| 2020-12-31 | $-40.36M | (m) | $-38.51M | $1.85M | (m) | (m) | (m) | $-40.38M | (m) | (m) | (m) | 0.95× |
| 2020-09-30 | $-46.80M | (m) | $-46.33M | $466.00K | (m) | (m) | (m) | $-45.88M | (m) | (m) | (m) | 1.01× |
| 2020-06-30 | $-51.52M | (m) | $-49.67M | $1.85M | (m) | (m) | (m) | $-49.69M | (m) | (m) | (m) | 1.00× |
| 2020-03-31 | $-55.19M | (m) | $-52.30M | $2.88M | (m) | (m) | (m) | $-55.49M | (m) | (m) | (m) | 0.94× |
| 2019-12-31 | $-54.65M | (m) | $-51.18M | $3.47M | (m) | $2.29M | (m) | $-53.24M | (m) | (m) | -2387.51% | 0.96× |
| 2019-09-30 | $-49.49M | (m) | $-46.02M | $3.47M | (m) | (m) | (m) | $-51.38M | (m) | (m) | (m) | 0.90× |
| 2019-06-30 | $-43.07M | (m) | $-40.85M | $2.22M | (m) | (m) | (m) | $-51.10M | (m) | (m) | (m) | 0.80× |
| 2019-03-31 | $-36.21M | (m) | $-34.94M | $1.27M | (m) | (m) | (m) | $-49.23M | (m) | (m) | (m) | 0.71× |
| 2018-12-31 | $-29.89M | (m) | $-29.07M | $819.00K | (m) | $2.15M | (m) | $-47.15M | (m) | (m) | -1389.77% | 0.62× |
| 2018-09-30 | $-27.24M | (m) | $-26.76M | $483.00K | (m) | $2.28M | (m) | $-44.48M | (m) | (m) | -1195.96% | 0.60× |
| 2018-06-30 | $-28.07M | (m) | $-27.24M | $831.00K | (m) | $3.39M | (m) | $-45.03M | (m) | (m) | -828.66% | 0.61× |
| 2018-03-31 | $-31.68M | (m) | $-29.60M | $2.08M | (m) | $5.23M | (m) | $-47.55M | (m) | (m) | -605.87% | 0.62× |
| 2017-12-31 | $-32.17M | (m) | $-29.77M | $2.40M | (m) | $8.00M | (m) | $-51.51M | (m) | (m) | -402.38% | 0.58× |
| 2017-09-30 | $-37.74M | (m) | $-33.40M | $4.33M | (m) | $13.69M | (m) | $-51.30M | (m) | (m) | -275.66% | 0.65× |
| 2017-06-30 | $-36.61M | (m) | $-31.23M | $5.37M | (m) | $15.57M | (m) | $-49.69M | (m) | (m) | -235.12% | 0.63× |
| 2017-03-31 | $-34.77M | (m) | $-30.70M | $4.07M | (m) | $17.44M | (m) | $-47.73M | (m) | (m) | -199.34% | 0.64× |
| 2016-12-31 | $-33.12M | (m) | $-29.39M | $3.72M | (m) | $17.36M | (m) | $-43.16M | (m) | (m) | -190.79% | 0.68× |
| 2016-09-30 | $-14.30M | (m) | $-12.09M | $2.21M | (m) | $12.65M | (m) | $-44.02M | (m) | (m) | -113.03% | 0.27× |
| 2016-06-30 | $-13.85M | (m) | $-12.98M | $870.00K | (m) | $24.71M | (m) | $-27.55M | (m) | (m) | -56.05% | 0.47× |
| 2016-03-31 | $-16.56M | (m) | $-15.43M | $1.13M | (m) | $22.11M | (m) | $-25.35M | (m) | (m) | -74.92% | 0.61× |
| 2015-12-31 | $-21.41M | (m) | $-19.95M | $1.46M | (m) | $19.26M | (m) | $-24.40M | (m) | (m) | -111.14% | 0.82× |
| 2015-09-30 | $-37.74M | (m) | $-35.87M | $1.87M | (m) | $17.76M | (m) | $-27.67M | (m) | (m) | -212.51% | 1.30× |
| 2015-06-30 | $-40.39M | (m) | $-35.95M | $4.44M | (m) | $7.16M | (m) | $-32.07M | (m) | (m) | -564.44% | 1.12× |
| 2015-03-31 | $-39.95M | (m) | $-35.07M | $4.88M | (m) | (m) | (m) | $-33.75M | (m) | (m) | (m) | 1.04× |
| 2014-12-31 | $-39.96M | (m) | $-34.46M | $5.50M | (m) | $5.22M | (m) | $-33.35M | (m) | (m) | -765.98% | 1.03× |
| 2014-09-30 | $-6.76M | (m) | $-87.00K | $6.68M | (m) | $32.60M | (m) | $-1.77M | (m) | (m) | -20.75% | 0.05× |
| 2014-06-30 | $-6.43M | (m) | $-1.33M | $5.09M | (m) | $28.32M | (m) | $-13.42M | (m) | (m) | -22.69% | 0.10× |
| 2014-03-31 | $-5.33M | (m) | $-947.00K | $4.38M | (m) | $28.66M | (m) | $-20.30M | (m) | (m) | -18.58% | 0.05× |
| 2013-12-31 | $-3.77M | (m) | $-487.00K | $3.29M | (m) | $29.50M | (m) | $-23.43M | (m) | (m) | -12.79% | 0.02× |
| 2013-09-30 | $-33.20M | (m) | $-31.73M | $1.47M | (m) | (m) | (m) | $-51.72M | (m) | (m) | (m) | 0.61× |
| 2013-06-30 | $-31.87M | (m) | $-31.58M | $294.00K | (m) | (m) | (m) | $-49.31M | (m) | (m) | (m) | 0.64× |
| 2013-03-31 | $-26.97M | (m) | $-26.49M | $475.00K | (m) | (m) | (m) | $-39.06M | (m) | (m) | (m) | 0.68× |
| 2012-12-31 | $-25.41M | (m) | $-24.58M | $826.00K | (m) | $2.39M | (m) | $-33.36M | (m) | (m) | -1061.32% | 0.74× |
| 2012-09-30 | $-25.74M | (m) | $-24.77M | $965.00K | (m) | (m) | (m) | $-29.21M | (m) | (m) | (m) | 0.85× |
| 2012-06-30 | $-24.83M | (m) | $-22.36M | $2.47M | (m) | (m) | (m) | $-26.39M | (m) | (m) | (m) | 0.85× |
| 2012-03-31 | $-24.06M | (m) | $-21.67M | $2.39M | (m) | (m) | (m) | $-23.96M | (m) | (m) | (m) | 0.90× |
| 2011-12-31 | $-17.31M | (m) | $-15.29M | $2.02M | (m) | (m) | (m) | $-20.10M | (m) | (m) | (m) | 0.76× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-12.23M | (m) | $-12.22M | $4.00K | (m) | (m) | (m) | $-14.34M | (m) | (m) | (m) | 0.85× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-19.53M | (m) | $-19.42M | $111.00K | (m) | (m) | (m) | $-20.12M | (m) | (m) | (m) | 0.97× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |